eGenesis Company
Xenotransplant
Investors
Headquarters:
USA
Industry:
Risk Mitigation
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Investors Number:
27
Investor Type:
Late Stage Venture
Last Funding Type:
Series C
Founded Date:
2014
Total Funding:
$265.00
Last Funding Date:
2021